易慕峰是一家致力于突破实体瘤治疗，给患者带来长期生存获益的免疫细胞治疗药物开发企业。
Investors 1
| Date | Name | Website |
| 26.10.2023 | triwise | en.triwise... |
Mentions in press and media 1
| Date | Title | Description | Source |
| 23.02.2024 | Immunofoco Announces the Dual Approval of IND Applications b... | - The first EpCAM targeted CAR-T product obtained US/CN IND approval. - Acceptable safety profiles a... | en.prnasia... |